Follow-Up Visit After Hospital Stay for Mental Illness (Within 30 Days of Discharge)
Identifying Attributes
Care Settings
Country
Publishing Organisation
Type of Quality Indicator
IOM Quality Dimension
Domain
Defining Attributes
Definition
Percentage of discharges for members 6 years of age and older who were hospitalised for treatment of selected mental health disorders and who had an outpatient visit, an intensive outpatient encounter or partial hospitalisation with a mental health practitioner within 30 days of discharge.
Numerator
Number from the denominator who had an outpatient visit, an intensive outpatient encounter or partial hospitalisation with a mental health practitioner within 30 days of discharge.
Denominator
Number of discharges for members 6 years of age and older who were hospitalised for treatment of selected mental health disorders.
Exclusions
Discharges followed by readmission or direct transfer to a non-acute inpatient care setting within the 30-day follow-up period, regardless of principal diagnosis for the readmission.
Use of Risk Adjustment
Risk Adjustments
None
Stratifications
Data Attributes
Type of Data Collection
Data Collection Methods
Health and Drug Plans.
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
NCQA website - National averages (Publicly available) web.archive.org/web/20241201162101/https://www.ncqa.org/hedis/measures/follow-up-after-hospitalisation-for-mental-illness/
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
Source and Reference Attributes
Evidence Source
web.archive.org/web/20241201162101/https://www.ncqa.org/hedis/measures/follow-up-after-hospitalization-for-mental-illness/ Medicare 2023 Part C & Display Measure Technical Notes page 3 www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn/PerformanceData www.ncqa.org/hedis/measures/transitions-of-care/ cmit.cms.gov/cmit/#/MeasureView?variantId=5199§ionNumber=1
Technical Specifications
Medicare 2023 Part C & Display Measure Technical Notes page 3 www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn/PerformanceData